Image 1
Lamotrigine
Product Images NDC 0228-1410
19 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0228-1410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
Image 11
Image 12
Lamotrigine 100 mg oral tablet blister card from Actavis Pharma, Inc. The blister pack features four rows of tablets protected by a foil backing with printed dosage information. The packaging clearly displays the strength of 100 mg per tablet.*
Image 13
Chemical structure diagram of Lamotrigine, showing its molecular framework with labeled atoms and bonds, as typically depicted in pharmaceutical labeling to illustrate the active ingredient.*
Image 14
Label for Lamotrigine Extended-Release Tablets, USP, 25 mg by Actavis Pharma, Inc. The label indicates a 30 tablet quantity and includes storage instructions and dispensing cautions. It mentions the product as once-a-day dosage, with a barcode and serialization coding area on the right side.*
Image 15
Label for Lamotrigine Extended-Release Tablets, USP 50 mg, once-a-day dosage form by Teva Pharmaceuticals. The label includes NDC 0228-1435-03, packaging of 30 tablets, and instructions for pharmacists to dispense a medication guide. Storage and handling details are also provided, along with a barcode and serialization coding area.*
Image 16
Label for Lamotrigine Extended-Release Tablets, USP 100 mg by Actavis Pharma, Inc. The label indicates the dosage form as extended-release tablets, with a package count of 30 tablets. It includes cautions for pharmacists to verify product dispensed and to provide the medication guide, with storage instructions and printing information. The label displays the NDC 0228-1422-03 and features the Teva logo, manufacturer address, and a serialization coding area.*
Image 17
Label for Lamotrigine Extended-Release Tablets, USP, 200 mg, by Teva Pharmaceuticals. The container holds 30 tablets with an extended-release formulation. The label includes storage instructions, dosage guidance references, pharmacist dispensing caution, and barcode with serialization coding area. Manufactured by Teva Pharmaceuticals, Parsippany, NJ.*
Image 18
Label for Lamotrigine Extended-Release Tablets, USP, 250 mg strength by Actavis Pharma, Inc. The label indicates 30 tablets per container for once-a-day dosing. It includes storage instructions, dispensing cautions, and manufacturer information for Teva Pharmaceuticals. The label also features a barcode and serialization coding area.*
Image 19
Label for Lamotrigine Extended-Release Tablets, USP 300 mg, supplied in a 30-tablet bottle by Actavis Pharma, Inc. The label includes dosage form and strength, caution to dispense the medication guide, storage instructions, and manufacturer details for Teva Pharmaceuticals.*
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Chemical structure of Lamotrigine, showing the arrangement of atoms and bonds, including chlorine-substituted aromatic ring and triazine ring with amino groups, consistent with the lamotrigine molecule.*
Image 8
Image 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
